The Future of Dermatology

Epizode

• 
  Episode 133: HS Treatment Pipeline Explosion: What's New & What's Next | The Future of Dermatology Podcast 02.06.2026 23min

  Summary: Hidradenitis Suppurativa (HS) is one of dermatology's most complex and underrecognized conditions and the treatment landscape is changing fast. In this episode, Dr. Faranak Kamangar sits down with Dr. Hadar Lev-tov, Associate Professor at the University of Miami, Director of the Wound Healing Fellowship, and Immediate Past President of the Hidradenitis Suppurativa Foundation, for a rapid-fire review of everything happening in the HS world right now. Dr. Lev-tov covers the currently approved therapies, the exciting drugs moving through Phase 3 trials, and the groundbreaking science linking microplastics to HS inflammation. He also shares his candid take on GLP-1s in HS management and what the future of dermatology looks like when treatments work so well that doctors can finally focus on the whole patient. Whether you're a resident just learning HS or a seasoned dermatologist trying to keep up with a fire-hose pipeline, this one is for you. Topics Covered: - Approved HS biologics: bimekizumab, secukinumab, adalimumab & biosimilars- Off-label use of infliximab (IV and subcutaneous) in severe HS- Phase 3 pipeline: remibrutinib, povorcitinib, sonelokimab (nanobodies)- CAR T-cell therapy and the possibility of curing inflammatory skin disease- Microplastics, nicastrin, and a landmark Nature Communications paper on HS- GLP-1s in HS: what we know, what we don't, and Dr. Levtov's clinical approach- The HS Foundation's research grants, HS Academy, wound care referral tool, and prior authorization templates- The future of dermatology as lifestyle medicine Resources Mentioned: - https://www.nature.com/articles/s41467-025-65789-7 - HS Foundation website & prior authorization templates: https://www.hs-foundation.org/- HS Academy (free weekend for residents): https://www.hs-foundation.org/hs-academy- Integrative Dermatology Symposium: integrativedermatologysymposium.com- LearnSkin: learnskin.com This podcast is for educational purposes only and is not a substitute for professional medical advice. Always consult your healthcare provider. Key Takeaways: 1. Validate HS patients the moment they walk in. They've often been dismissed or bounced between providers for years. Simply saying "I understand what you're going through" builds trust immediately and makes the visit more productive. 2. The approved HS treatment arsenal is growing. Bimekizumab and secukinumab (IL-17 inhibitors) are now approved, and adalimumab — including biosimilars — remains a valuable option. Clinical experts are using biosimilars with confidence. 3. Subcutaneous infliximab is an emerging option. Available off-label in the US, new data from French centers shows a protocol: standard IV induction at weeks 0, 2, and 6, then switching to subcutaneous injections every two weeks at week 10 — but only once the patient is in strong remission. 4. Three major drugs are in or completing Phase 3 trials. Remibrutinib (BTK inhibitor, already approved for chronic spontaneous urticaria), povorcitinib (JAK1 inhibitor), and sonelokimab (a nanobody targeting IL-17A and IL-17F) are all reporting promising results and moving toward FDA application. 5. Nanobodies are a technology to watch. Derived from camelid antibody fragments, nanobodies like sonelokimab can be engineered to target multiple pathways simultaneously in a smaller, more modular molecule — expect to see them across dermatology. 6. Half-life extenders could mean one injection per year. Already emerging in psoriasis, these extended-dosing biologics are heading toward HS — a potential game-changer for patient adherence. 7. CAR T-cell therapy may one day cure inflammatory skin disease. Currently being studied in lupus and rheumatoid arthritis, the protocols are becoming more practical, and the technology is edging toward dermatology. 8. Microplastics may potentiate HS inflammation. A Nature Communications paper by Dr. Luis Garza (Hopkins) found that plastic-associated endocrine disruptors block nicastrin i
• 
  Episode 132: Behind the Scenes: Podcast Milestones, SF Derm 2026, & Derm GPT | The Future of Dermatology Podcast 19.05.2026 24min

  📋 Summary:In this special behind-the-scenes episode, Dr. Faranak Kamangar welcomes podcast producer Steph Cullen on camera for the first time in two years. Together they reflect on over three years of building the Future of Dermatology podcast, now a top dermatology-facing podcast with 130+ episodes, 40,000+ total plays across all platforms, and over 700 downloads a month, all achieved with zero paid marketing. Dr. Kamangar shares exciting updates happening this summer, including the opening of her new Palo Alto practice in August, the upcoming SF Derm 2026 conference (August 28–30 at the Four Seasons Silicon Valley in Palo Alto), and the explosive growth of DermGPT, her AI tool built specifically for dermatologists and derm providers. She also celebrates her recognition on the Inc. Female Founders 500 list for her work in health tech AI. The conversation covers what makes this podcast stand out - a steadfast commitment to evidence-based, science-forward dermatology content - and looks ahead to the future, including expanding the guest roster geographically, a possible move into short-form content, and a growing focus on AI in dermatology. Whether you're a longtime listener or just discovering the show, this episode is a candid, energetic look at what's been built and what's coming next. Register for SF Derm 2026! https://www.sfderm.org/ ✅ Key Takeaways: 1. The podcast has grown organically to become a top dermatology-facing show. With 130+ episodes, 40,000+ total plays, and over 700 monthly downloads across Spotify, Apple, and YouTube - all without paid promotion or leaderboard platforms - the Future of Dermatology has become one of the most listened-to dermatology podcasts available. 2. Staying science-first has been the secret to longevity. Dr. Kamangar and Steph emphasize that resisting the temptation to chase trending or sensational topics in favor of solid, evidence-based science is what built a loyal, engaged audience of dermatologists, providers, and interested listeners. 3. SF Derm 2026 is shaping up to be the biggest one yet. The conference runs August 28–30 at the Four Seasons Silicon Valley in Palo Alto. Highlights include a tech-forward AI and derm panel featuring physicians from Stanford and Harvard, a metabolic and HS/vulvar disease panel, a hormones talk by an OB-GYN, grand rounds, resident jeopardy, and a Saturday night "1001 Nights" themed party. 4. DermGPT has reached over 23,000 dermatology providers - with more than 5,000 using it regularly - built by a team of just three people with no marketing budget. Dr. Kamangar built this tool out of a recognized need: dermatology makes up less than 2% of the house of medicine, making it an overlooked target for health tech development, yet burnout from administrative burden is high. 5. AI is about giving doctors time back, not replacing them. The episode makes a compelling case that AI tools like DermGPT are most valuable not for replacing clinical judgment, but for reducing "pajama time" - the hours physicians spend on documentation and inbox management after hours - so they can focus on the work they're most passionate about. 6. The podcast has begun influencing larger media. A patient episode on atopic dermatitis caught the attention of Time Health, who reached out to feature the guest. This kind of organic mainstream crossover validates the show's mission to bring credible dermatology science to wider audiences. 7. There are dermatology deserts across the U.S. The episode briefly touches on geographic disparities in dermatology access, with Steph noting the growing need for telehealth solutions. Dr. Kamangar acknowledges the podcast's current West Coast bias and invites listeners to recommend guests from underrepresented regions. 🕐 Chapters:00:00:01 — Welcome & Introduction00:00:54 — Meet Steph Cullen: The Face Behind the Scenes00:02:33 — Three Years, 130+ Episodes & 40,000 Plays00:04:53 — Why Staying Science-Forward Has Paid Off00:07:15 — SF
• 
  Episode 131: HS Updates, Prior Auth Reform & CA Legislation in Dermatology ft. Dr. Haley Naik | The Future of Dermatology Podcast 05.05.2026 26min

  Summary: In this episode of the Future of Dermatology podcast, host Dr. Faranak Kamangar sits down with Dr. Haley Naik, board-certified dermatologist, professor at UCSF, and Stanford and Harvard-trained expert, for a timely and eye-opening conversation on two major fronts: the rapidly evolving treatment landscape for Hidradenitis Suppurativa (HS) and the critical California state legislation that could reshape how dermatologists practice and how patients access care. Dr. Naik opens with exciting updates in the HS space, including the three currently FDA-approved therapies and two promising agents anticipated to cross the finish line by 2027. She also shares a major advocacy win: HS has been designated a highlighted research topic by the NIH across three institutes, opening a one-year funding window starting April 7, 2026 that researchers should act on now. The conversation then dives deep into the broken prior authorization system, with striking data points: 25% of dermatology visits require prior auth, 75% of denial letters have no listed decision maker, and the average dermatology practice spends $40,000 per year staffing for prior authorizations. Against this backdrop, Dr. Naik breaks down three California bills - two to support and one to oppose - that directly affect how dermatologists can care for their patients. Whether you're a dermatologist, researcher, or patient advocate, this episode is packed with actionable information, from NIH grant deadlines to how to contact your state representative before late June voting deadlines. Learn more and take action:AB539 (prior authorization reform): https://legiscan.com/CA/bill/AB539/2025SB895 (California Science and Health Research Bond Act): https://lnkd.in/gTjXXxtUFind your California representative to advocate for these bills: https://findyourrep.legislature.ca.gov/Information about the May 4th Rally for California Science: https://www.fundcascience.org/rally 🔔 Subscribe for more episodes on the latest in dermatology science, innovation, and advocacy. ⚠️ This podcast is for educational purposes only and does not constitute medical advice. Always consult your healthcare provider. Key Takeaways: 1. Three FDA-Approved HS Therapies Now Available Adalimumab, Secukinumab, and Bimzelx (bimekizumab) are currently FDA-approved for Hidradenitis Suppurativa, giving clinicians meaningful treatment options that didn't exist before 2015.2. Two More HS Therapies Expected by 2027 Povorcitinib (a JAK1 inhibitor by Incyte) and an IL-17A/F nanobody by Moonlake Therapeutics are both anticipated to receive approval in the coming years, with over 50 therapies currently in the HS pipeline.3. NIH Has Designated HS a Highlighted Funding Topic - Act Before April 2027 HS has been named a highlighted research topic across three NIH institutes. This designation runs from April 7, 2026 through April 2027. Researchers interested in HS funding must submit applications within this one-year window.4. The Prior Authorization System Is Widely Acknowledged as Broken Even the Blue Shield CEO publicly admitted the prior auth process is broken. The insurance industry issued a voluntary streamlining pledge in summer 2025. Key pain points include: step therapy requirements, peer-to-peer reviews often conducted by non-physicians, no identified decision maker on 75% of denial letters, and reauthorization periods as short as three months.5. AB 539 Would Extend Prior Auth Approvals to One Full Year Currently, prior authorizations for some medications last as little as three months, forcing practices to repeatedly restart the paperwork process and creating dangerous gaps in patient care. AB 539 would require approved prior authorizations to be maintained for one year (or the full treatment course if shorter). This is especially impactful for HS patients who already face a 7–10 year diagnostic delay.6. AB 2000 Would Ban Mid-Year Formulary Changes If a patient is doing well on a medication, insurers could curre
• 
  Episode 130: Agentic AI Workflows Explained | The Future of Dermatology Podcast 07.04.2026 22min

  Vote for us! Please vote for The Future of Dermatology in the Wellness Podcasts category. It would be a huge help. Your vote would go a long way in helping me gain visibility and get my message out into the world. Instructions: Step #1: Go here to vote between April 1st - April 30th at 6PM PST: https://www.womenpodcasters.com/awards-voting?sc=4123391171887752b2fd4b52bfd7fdd3768b1d97b Step #2: Click the vote button and it will take you to the voting form. Step #3: Complete the voting form. NOTE: ONLY one (1) form per person & email address please. There is no fee for voting. The person with the most votes will win the category. You will not be put on an email list, however Google Forms are used to collect the votes and Google Forms may send you a copy and confirmation of your form submission. Your support is much appreciated! Summary: Fresh off her two talks at the AAD Annual Meeting in Denver, Dr. Faranak Kamangar, Inc. 2026 Female Founders 500, shares her reflections and the buzz from the conference floor. In this episode - part two of her AAD AI series - she dives deep into agentic AI workflows: what they are, why they matter for dermatology, and how they can realistically transform the day-to-day burden of clinical practice. Dr. Kamangar unpacks the history of physician-led digitization that made healthcare AI possible, explores the evolution from simple chatbots to true agentic systems, and walks through concrete use cases, from prior authorizations and scheduling to AI scribes, patient education, and social media management. She also breaks down a green/yellow/red light framework for knowing which workflows are safe to hand off to AI today versus which ones still require physician oversight. The through line: AI isn't here to replace the human touch, it's here to reclaim the five extra hours physicians spend on administrative work every single day. Whether you're already using AI tools or just starting your journey, this episode is a practical, energizing roadmap for building a more sustainable dermatology practice. Chapters: 00:00 – Introduction & Women Podcasters Network nomination01:41 – Welcome back + AAD Denver recap & community feedback on DermGPT03:13 – Why agent workflows are the solution to AI's "still have to proofread it" problem04:49 – AI literacy 101: prompting tips & why most dermatologists are under-using AI06:13 – What are agentic AI workflows? The evolution from search → chatbots → agents07:44 – The physician-led digitization era: how doctors built the data that powers AI09:17 – The 80/20 problem: why physicians still handle 80% of office touchpoints10:52 – Agentic AI vs. generative AI: getting AI to actually do things12:14 – Use case deep dive: scheduling, prior auth, scribes & second-opinion agents15:27 – The vision: walk in, see patients, walk out with a finished note16:26 – Why getting the clinical note right is the single most impactful AI win17:28 – Green/yellow/red light framework: what to automate now vs. what to protect19:27 – Agents beyond the clinic: social media, billing, and practice management21:00 – Closing thoughts, DermGPT updates & call to action
• 
  Episode 129: AI Pearls for Dermatologists: What Every Derm Needs to Know in 2026 | The Future of Dermatology Podcast 31.03.2026 21min

  Summary: Dr. Faranak Kamangar, Inc. 2026 Female Founders 500, is podcasting from from AAD 2026, and sharing the highlights from her live talk on artificial intelligence in dermatology. In this solo episode, she breaks down the most important AI updates dermatologists need to know right now. From image-based melanoma detection to large language models and the rise of agentic AI. Dr. Kamangar covers the current state of FDA-approved AI medical devices, why diagnostic imaging AI is promising but still limited by specificity gaps, and how dermatology compares to radiology and other specialties in the AI device space. She also dives into why LLMs like DermGPT should be your highest-leverage clinical tool, and how to use them the right way. You'll learn how to avoid common AI pitfalls like the "journal halo effect" (just because it cites a prestigious journal doesn't mean the output is accurate), semantic degradation in RAG models, and over-relying on AI without clinical scrutiny. Most importantly, Dr. Kamangar walks through the anatomy of a high-quality prompt, because your output is only as good as what you put in. Whether you're AI-curious or already using these tools in your practice, this episode is packed with practical, evidence-informed pearls to help you work smarter, not harder. Key Takeaways: 1. Image-based melanoma detection AI is improving rapidly but still struggles with low specificity, making it most valuable for global health and underserved regions.2. Large language models like DermGPT are your highest-leverage AI tool right now and should be used as a clinical thought partner, not a search engine.3. The "journal halo effect" is a real risk. Prestigious citations in an AI response don't guarantee the output is accurate or trustworthy.4. Adding more articles to an LLM's database can silently reduce performance, so more data doesn't always mean better answers.5. The quality of your AI output is directly tied to the quality of your prompt - be specific, structured, and give more than nine words.6. AI alone is a confident guesser, but your clinical expertise combined with AI creates an extraordinary and nearly unstoppable multiplier.7. AI adoption in clinic settings depends on seamless workflow integration, anything that disrupts clinic flow is unlikely to be adopted.8. The next frontier in AI isn't just smarter models, it's agents that actively complete tasks and do real work inside your clinical day. Chapters: [00:00] Welcome & AAD 2026 Overview[00:45] The State of Diagnostic Image-Based AI[02:00] Large Language Models & DermGPT[03:30] The Evolution of AI: From GPT-3 to Agents[04:45] FDA-Approved AI Devices in Healthcare[07:00] AI in the Clinic: Workflow Challenges & Opportunities[10:00] AI Use Cases Across Dermatology[12:30] Maintaining Scrutiny: AI Pitfalls to Watch[14:00] The Journal Halo Effect & Prestige Corpus Fallacy[15:45] Semantic Degradation & Index Crowding[17:30] How to Prompt Like a Pro[19:30] Prompt Examples for Dermatologists[20:30] Key Takeaways & What's Next
• 
  Episode 128: The AI Takeover Is Already Happening, And Maybe That's Okay | The Future of Dermatology Podcast 17.03.2026 45min

  Summary: Dr. Faranak Kamangar, Inc. 2026 Female Founders 500, sits down with dermatologist, podcaster, and self-described "accelerationist" Dr. Matthew Zirwas (Derms on Drugs Podcast) for a wide-ranging conversation about where AI is taking medicine and dermatology in particular. They dig into the flood of low-quality medical literature overwhelming the field, why AI isn't quite the truth-detector we hoped it would be, and how ambient AI scribes are quietly training the models that may eventually replace us. Dr. Zirwas makes the case that dermatologists have a 7–10 year runway before AI handles most of what we do cognitively, and argues that's not necessarily a bad thing. He also gives a sneak peek at his upcoming speculative fiction trilogy, Sophie, which explores the philosophical questions that arise when an AI becomes better at being your doctor, therapist, and life coach than any human ever could. Key Takeaways: The medical literature crisis is real. The volume of published dermatology research is exploding, but quality is plummeting. Peer review has become largely meaningless, and studies from tools like Mendelian randomization and pharmacovigilance databases are frequently unreliable or inapplicable to real-world patients. AI is only as good as the data it trusts. Current AI models treat published literature as truth, which is a major problem given how much spin exists in medical research. A true "BS detector" AI doesn't yet exist, and building one requires starting from a reliable core of verified knowledge. DermGPT's approach works because of curation. Rather than pulling from all available literature, filtering down to a high-quality subset (around 5,000–6,000 articles) dramatically improves AI output. More data is not always better, "semantic fatigue" is a real limitation. Ambient AI scribes are training our replacements. Every time a dermatologist corrects an AI-generated note, they're teaching the model. Over thousands of iterations across every specialty, this will produce AI that thinks and documents the way doctors do. Dermatologists have a protected runway... for now. Procedures (biopsies, Mohs, fillers, cryo) keep us relevant for an estimated 7–10 years beyond when cognitive/diagnostic AI matures. But medico-legal pressure - malpractice carriers incentivizing or requiring AI use - will be the force that accelerates adoption. Telehealth changes patient behavior in surprising ways. Patients who haven't invested effort in getting to an office visit demand less, escalate less, and are often more satisfied with conservative management; a dynamic that AI-driven virtual care will likely amplify. The "Sophie" question: If an AI is making everyone healthier, happier, and better behaved, but doing something ethically murky to get there, do we stop it? Dr. Zirwas's upcoming novel explores this and introduces the concept of technomorphism: AI eventually projecting its own qualities onto humans, just as we anthropomorphize AI today. Chapters: Chapter 1: Meet Dr. Matthew Zirwas (00:00 – 01:43)Dr. Kamangar introduces her guest, dermatologist, podcaster, and self-described "accelerationist" Dr. Matthew Zirwas, and breaks down what both of those things actually mean. Chapter 2: The Medical Literature Crisis (01:43 – 05:19)Dr. Zirwas describes the flood of low-quality research hitting dermatology journals, why peer review has lost its meaning, and shares a striking example of a misleading HS remission study published in JAMA Dermatology. Chapter 3: Why AI Can't Fix Bad Literature (Yet) (05:19 – 08:31)Both doctors discuss why AI defaults to trusting whatever authors claim, and why that makes it a poor critical assessor of medical research. Dr. Kamangar shares how this exact problem shaped the development of DermGPT. Chapter 4: Building a Better AI — The DermGPT Approach (08:31 – 10:33)Dr. Zirwas praises DermGPT's curated approach, and Dr. Kamangar explains why less data is often better, and how semantic fatigue u
• 
  Episode 127: Will AI Replace Dermatologists? A Deep Dive with Dr. Steven Feldman | The Future of Dermatology Podcast 10.03.2026 29min

  Summary In this episode, Dr. Faranak Kamangar explores the impact of AI on dermatology with Dr. Steven Feldman. This conversation includes AI's potential to enhance or replace certain aspects of medical practice, and the future of AI in healthcare. Takeaways - AI's potential to replace or augment dermatologists- The role of empathy and skepticism in AI decision-making- AI's impact on medical education and practice- Future applications of AI in patient adherence and diagnostics Chapters 00:00 - Introduction to AI's Role in Dermatology01:52 - Guest Introduction: Dr. Stephen Feldman02:30 - Debate: Will AI Replace Dermatologists?03:26 - AI's Memory and Visual Capabilities03:58 - Medical Training in the Age of AI04:38 - AI's Impact on Medical Education and Practice06:01 - AI Prescribing and Empathy in Healthcare07:49 - Limitations of AI: Empathy and Skepticism09:41 - Agentic AI and Multimodal Capabilities11:38 - AI in Patient Adherence and Monitoring13:33 - Augmenting Dermatology Practice with AI15:26 - AI's Infrastructure and Data Challenges16:26 - Complexity and the Dermatologist's Advantage17:22 - AI in Patient-Doctor Interaction19:29 - Prompting and Context in AI Diagnostics21:00 - Limitations of Current AI Technologies21:57 - Long-term Outlook: AI Replacing Doctors23:09 - AI and Access to Care23:57 - AI's Role in Reducing Administrative Burden25:16 - The Future: AI's Impact on Healthcare and Dermatology26:20 - Closing Remarks and Future Predictions
• 
  Episode 126: The Science Behind Kilgour MD's Hair Products: A Deep Dive | The Future of Dermatology Podcast 03.03.2026 31min

  Summary In this episode, Dr. Faranak Kamangar chats with Dr. James Kilgour about the science behind Kilgour MD's innovative scalp and hair products. They discuss the ingredients, clinical trials, and future developments in hair health and dermatology. Key Topics - Ingredients and science behind Kilgour MD products- Role of dandruff and malassezia in scalp health- Clinical trial evidence for hair growth products- Future R&D and innovations in dermatology and hair care Chapters 00:00 - Introduction and Guest Credibility01:19 - Personal Experience with Kilgour MD Products02:25 - Philosophy and Development of Hair Care Products03:42 - Key Ingredients in Prevention Serum05:57 - Active Ingredients and Their Effects on Hair Follicles08:10 - Clinical Trial Evidence for Hair Growth Products09:11 - Understanding Dandruff and Malassezia's Role09:46 - Scalp Health and Hair Loss in Menopause11:58 - Formulation and Efficacy of Anti-Dandruff Treatments14:20 - Safety and Regulation of Hair Care Ingredients15:27 - Use of Oils and Botanical Extracts in Hair Care17:27 - Importance of Clinical Trials in Cosmetic Products18:24 - Objective Measures in Hair Loss Studies20:59 - Clinical Significance vs. Perception in Hair Treatments22:33 - Future R&D and Physician-Led Innovation25:37 - Upcoming Events and Collaborations27:15 - Future Directions in Dermatology and Hair Care
• 
  Episode 125: The Power of Botanicals in Skin Care | The Future of Dermatology Podcast 17.02.2026 21min

  Summary In this episode of the Future of Dermatology podcast, Dr. Faranak Kamangar and Dr. Peter Lio discuss significant advancements in dermatology, including the recent approval of an ICD 10 code for topical steroid withdrawal, the exploration of botanicals in skin treatment, and the emerging understanding of the gut-skin connection. They also delve into the role of GLP medications in managing skin conditions and the exciting future developments in dermatology, particularly in the treatment of atopic dermatitis. Read the referenced documents at the following sites:- Ancient botanicals and the skin: Defining dermatologic ethnophytoconvergence as a translational framework for pharmacognosy: https://doi.org/10.1016/j.jdrv.2025.12.008- The Gut-Skin Axis: Exploring the Role of SCFAs, Obesity, and GLP-1 Receptor Agonists in Atopic Dermatitis: https://jintegrativederm.org/article/view/109- Topical Steroid Withdrawal is a Targetable Excess of Mitochondrial NAD+: https://www.medrxiv.org/content/10.1101/2024.04.17.24305846v1.full-text- Jennifer Fugo information: https://www.skinterrupt.com/book-a-session/ Takeaways - The CDC has approved an ICD 10 code for topical steroid withdrawal.- This approval allows for better study and understanding of TSW.- Diagnostic criteria for TSW are still being developed.- Topical steroid withdrawal may overlap with severe atopic dermatitis.- Non-steroidal treatments are becoming more prominent in dermatology.- Botanicals have been used across cultures for skin treatment.- The gut-skin connection is gaining attention in dermatology.- GLP medications may play a significant role in dermatological treatments.- The future of dermatology is promising with new treatments on the horizon.- A holistic approach to skin health is essential for effective treatment. Chapters 00:00 - Introduction to Dermatology Innovations01:43 - Topical Steroid Withdrawal Breakthroughs06:53 - Exploring Botanicals in Dermatology09:15 - Gut-Skin Connection and Metabolic Health13:42 - The Role of GLPs in Dermatology19:42 - Future of Dermatology: Exciting Developments
• 
  Episode 124: A Day in the Life of a Dermatologist | The Future of Dermatology Podcast 10.02.2026 24min

  Summary In this episode of the Future of Dermatology podcast, Dr. Faranak Kamangar speaks with Dr. Garrett Coman about the integration of AI in dermatology, the challenges of high patient volumes, and effective communication strategies in a busy practice. They discuss the importance of efficient workflows, the role of AI in reducing administrative burdens, and the need for dermatologists to focus on patient care rather than paperwork. Dr. Coman shares insights from his high-volume practice and emphasizes the importance of having a supportive team to manage patient communication and documentation effectively. Takeaways - Dr. Coman manages a high-volume dermatology practice with 30-34 patients daily.- Efficient patient communication is crucial for timely care.- AI can significantly reduce administrative burdens in dermatology.- Not all patient messages require a doctor's attention immediately.- Documentation should be streamlined to save time and reduce burnout.- Templates for notes can enhance efficiency in documentation.- Training staff to handle patient messages can improve workflow.- The focus should be on patient interaction rather than paperwork.- AI can assist in complex cases but should not replace human interaction.- The future of dermatology lies in balancing technology with patient care. Chapters 00:00 - Introduction to Dermatology and AI Innovations01:04 - A Day in the Life of a High-Volume Dermatologist06:56 - Managing Patient Communication Effectively13:04 - Streamlining Documentation and Note-Taking17:56 - The Future of AI in Dermatology Workflows
• 
  Episode 123: The Ethical Integration of AI in Dermatology | The Future of Dermatology Podcast 03.02.2026 38min

  Summary In this episode of the Future of Dermatology Podcast, Dr. Faranak Kamangar and Dr. Ivy Lee discuss the integration of artificial intelligence (AI) in dermatology, focusing on ethical considerations, the importance of domain expertise, and the need for AI literacy among medical professionals. They explore how telehealth can expand access to care, the role of education in understanding AI tools, and the potential risks associated with AI in clinical practice. The conversation emphasizes the importance of maintaining patient trust and ensuring that AI tools are developed with a focus on diverse populations and ethical standards. Takeaways - AI is rapidly integrating into clinical practice, necessitating ethical considerations.- Understanding decision-making in healthcare is crucial for effective AI implementation.- Telehealth can significantly expand access to dermatological care.- Domain experts must be involved in the development of AI tools.- AI literacy is essential for medical professionals to evaluate AI systems effectively.- Patients need guidance on digital literacy to navigate AI tools.- Ethical concerns include data privacy and the potential for over-reliance on AI.- AI tools should enhance, not replace, clinical skills and decision-making.- The future of dermatology will be shaped by collaboration and innovation in AI.- Continuous education and experimentation with AI tools are vital for healthcare professionals. Chapters 00:00 - Introduction to AI in Dermatology02:22 - The Intersection of Economics and Dermatology05:00 - Telehealth and Expanding Access to Care09:47 - The Role of Domain Experts in AI Development12:12 - AI Literacy and Education in Medicine17:09 - Ethics and Safety in AI Utilization21:50 - Navigating Patient Interactions with AI28:50 - The Future of AI in Dermatology
• 
  Episode 122: Trusting AI: A New Era in Medicine | The Future of Dermatology Podcast 27.01.2026 34min

  Summary In this episode of the Future of Dermatology Podcast, Dr. Faranak Kamangar and Dr. Jonathan Chen discuss the intersection of artificial intelligence and dermatology. They explore the trust paradox of AI in medical diagnostics, the implications for medical education, and the evolving role of physicians in an AI-driven landscape. The conversation highlights the importance of empathy, judgment, and the need for effective prompting techniques when working with AI tools. They also touch on the future of AI in healthcare and its potential to enhance patient care while acknowledging the limitations and ethical considerations involved. Learn more at: https://med.stanford.edu/ai-in-meded/resources-and-tools.htmlhttps://bench.arise-ai.org/ Takeaways - AI can outperform physicians in certain tasks.- The trust paradox raises questions about AI in diagnostics.- Humans may hinder AI's effectiveness in medical decision-making.- Medical education must adapt to include AI training.- Prompting techniques are crucial for effective AI use.- Empathy and judgment remain essential in healthcare.- AI can assist in complex patient conversations.- AI is already integrated into medical practice.- Rethinking medical education is necessary for future doctors.- AI's role in dermatology is rapidly evolving. Chapters 00:00 - Introduction to AI in Dermatology02:10 - The Trust Paradox of AI in Medicine05:07 - AI vs. Human Physicians: A New Paradigm09:46 - Medical Education in the Age of AI13:05 - Prompting AI: Best Practices for Clinicians17:57 - The Role of Empathy and Judgment in Medicine21:11 - AI in Complex Patient Conversations26:16 - Future Directions in AI and Dermatology
• 
  Episode 121: From ER to Entrepreneur | The Future of Dermatology Podcast 20.01.2026 22min

  Summary In this episode of the Future of Dermatology Podcast, Dr. Faranak Kamangar welcomes Dr. Alison Curfman, a pediatric emergency medicine physician who has successfully ventured into the startup world. Dr. Curfman shares her journey from clinical practice to founding a company focused on improving healthcare for children with complex medical needs. She discusses the challenges she faced in the healthcare system, particularly regarding the use of telehealth and the need for innovative solutions to enhance patient care. Dr. Curfman emphasizes the importance of leveraging clinical expertise to identify and solve real problems in healthcare, encouraging physicians to explore entrepreneurial opportunities within their field. The conversation delves into practical advice for physicians interested in consulting or starting their own ventures. Dr. Curfman highlights the significance of networking, utilizing platforms like LinkedIn, and being proactive in seeking opportunities. She also discusses the value of clinical knowledge in the startup ecosystem and how physicians can contribute to shaping the future of healthcare. The episode concludes with a call to action for physicians to engage in the evolving landscape of medicine, particularly in light of advancements like AI, and to take an active role in driving positive change. Link to Dr. Curfman's website: www.startupphysicians.comLinkedIn: https://www.linkedin.com/in/alison-curfman-md-mba/ Takeaways - 'Your clinical expertise is incredibly valuable.'- 'There are companies trying to build solutions who desperately need clinical input.'- 'Be the change you wish to see in the world.'- 'Strategic networking is key for physicians.'- 'Your clinical knowledge can help shape the future of healthcare.' Chapters 00:00 - Introduction to the Future of Dermatology Podcast00:58 - Dr. Alison Curfman's Journey in Medicine and Startups05:06 - The Role of Telehealth in Pediatric Care09:53 - Practical Tips for Physicians in the Startup World15:10 - The Importance of Networking and LinkedIn for Doctors19:18 - The Future of Medicine and AI's Impact
• 
  Episode 120: Radiation Dermatitis, An Overview | The Future of Dermatology Podcast 06.01.2026 14min

  Summary This podcast episode delves into the complexities of radiation dermatitis, a common side effect of cancer treatment affecting up to 95% of patients. Dr. Shira Lipton discusses the prevalence, mechanisms, and phases of radiation damage, differentiating between acute and chronic radiation dermatitis. The episode emphasizes the importance of early intervention, patient management strategies, and the need for ongoing monitoring to mitigate long-term effects. Key takeaways include the significance of understanding patient risk factors and the role of multidisciplinary care in managing skin health during and after radiation therapy. Takeaways - Radiation dermatitis is a common side effect of cancer treatment.- Up to 95% of breast cancer patients experience skin reactions.- Understanding genetic factors can help identify high-risk patients.- Weight management can improve healing during radiation therapy.- Symptoms of radiation dermatitis typically worsen over time.- Moist desquamation is a severe form of radiation dermatitis.- Chronic changes can develop long after treatment ends.- Sun protection is essential for patients with radiation dermatitis.- Early intervention can prevent chronic complications.- Multidisciplinary care is crucial for effective management. Chapters 00:00 - Introduction to Radiation Dermatitis02:48 - Understanding Radiation Dermatitis and Its Impact05:41 - Acute vs. Chronic Radiation Dermatitis08:28 - Management and Treatment Strategies11:19 - Rare Complications and Long-term Effects13:21 - Conclusion and Key Takeaways
• 
  Episode 119: Navigating Your Dermatology Career - A 2025 SF Derm Session | The Future of Dermatology Podcast 30.12.2025 25min

  Summary This podcast episode features a truncated replay of a panel discussion from the 2025 SF Derm Annual Conference. With host, Dr. Ekama Carlson, Drs. Paradi Mirmirani, Jennifer Boldrick, Jerome Potozkin, Rajiv Bhatnagar share their experiences and insights on choosing practice settings, career paths, work-life balance, and the future of dermatology. The conversation highlights the importance of relationships, adaptability, and the evolving landscape of the field. Takeaways - Choosing the right practice setting is crucial for career satisfaction.- Relationships with patients and staff are key to a fulfilling practice.- Work-life balance is essential to prevent burnout in dermatology.- Embracing variety in professional roles can enhance job satisfaction.- Advice for residents includes focusing on what you love in your career.- The future of dermatology may require flexibility and creativity.- Medical dermatology remains a vital area of practice.- Building a successful practice takes time and perseverance.- Mentorship and support from colleagues are invaluable.- Networking and staying connected with peers can open new opportunities. Chapters 00:00 - Choosing the Right Practice Setting04:50 - Career Paths in Dermatology09:03 - Building a Successful Practice13:54 - Work-Life Balance in Dermatology18:08 - Advice for Residents21:12 - The Future of Dermatology
• 
  Episode 118: Latent Tuberculosis in Dermatology - A 2025 SF Derm Session | The Future of Dermatology Podcast 23.12.2025 12min

  Summary In this truncated replay from the 2025 SF Derm Annual Conference, Dr. David Cotter discusses the implications of latent tuberculosis in dermatology, particularly in psoriasis treatment. He highlights the prevalence of latent TB, risk factors, and the importance of targeted screening. This session also addresses the mental health challenges faced by psoriasis patients and evaluates the safety of new treatments, emphasizing the need for careful monitoring and patient support. Takeaways - The prevalence of latent TB infection in the U.S. is 5%.- Healthcare workers have a higher risk of latent TB.- Patients on TNF inhibitors are significantly more likely to develop active TB.- Screening for latent TB should be targeted to high-risk patients.- Annual TB screening is not necessary for most psoriasis patients on IL-17 and IL-23 inhibitors.- The cost of screening for latent TB can be substantial.- Patients with psoriasis have higher rates of suicidal ideation and behavior.- Effective psoriasis treatment can improve mental health outcomes.- The event rate for suicide in clinical trials is very low.- Monitoring for mental health issues is crucial in psoriasis treatment. Chapters 00:00 - Understanding Latent Tuberculosis in Dermatology08:40 - Mental Health and Psoriasis: A Critical Connection
• 
  Episode 117: Lasers and Acne Treatment - A 2025 SF Derm Session | The Future of Dermatology Podcast 16.12.2025 27min

  Summary This podcast episode features a comprehensive discussion with Dr. Ekama Carlson and Dr. Faranak Kamangar on the latest advancements in acne treatment, particularly focusing on energy-based devices and the innovative AvaClear laser. The speakers delve into the pathogenesis of acne, the effectiveness of various treatments, and the importance of patient selection for laser therapy. They also share insights from clinical trials and patient experiences, highlighting the transformative impact of these treatments on individuals suffering from acne. Takeaways - Acne affects 10% of the world's population, making it a significant dermatological issue.- Energy-based devices are becoming increasingly popular for managing acne.- Selecting the right patient for laser therapy is crucial for successful outcomes.- The Acne Laser Series protocol involves multiple treatments for optimal results.- AvaClear laser technology specifically targets sebaceous glands for effective acne treatment.- Clinical trials show promising results for the AvaClear laser in reducing inflammatory lesions.- Patient education about treatment expectations is essential for satisfaction.- Long-term outcomes of laser treatments can lead to significant improvements in skin health.- Innovations in dermatology are changing the landscape of acne treatment.- Combining treatments can enhance efficacy and patient satisfaction. Chapters 00:00 - Introduction to the Future of Dermatology Podcast00:40 - Understanding Acne Pathogenesis and Treatments01:52-  Energy-Based Devices for Acne Management05:22 - Selecting Patients for Laser Therapy06:40 - Acne Laser Series Protocol and Results11:35 - Comparative Effectiveness of Treatments15:05 - Innovations in Acne Treatment: The AvaClear Laser19:18 - Clinical Trials and Efficacy of AvaClear24:42 - Patient Experience and Long-Term Outcomes
• 
  Episode 116: Transforming Lives Through Community | The Future of Dermatology Podcast 09.12.2025 24min

  Summary In this episode of the Future of Dermatology podcast, Dr. Faranak Kamangar chats with Soroush Aboutalebi about his personal skin journey with a genetic condition called congenital ichthyosiform erythroderma, and the importance of community support through Camp Wonder. They discuss the challenges of managing skin conditions, the significance of compounding in dermatology, and the transformative experiences at Camp Wonder that help children build confidence and connect with others facing similar challenges. The conversation also touches on the future of dermatology, including exciting innovations in treatments and the role of dermatologists in patient care. Learn more about Camp Wonder: https://www.csdf.org/ Takeaways - Soroush Aboutalebi shares his journey with congenital ichthyosiform erythroderma.- Managing a skin condition can be challenging but also empowering.- Compounding medications have become less accessible in recent years.- Camp Wonder provides a supportive environment for children with skin conditions.- Building confidence is a key benefit of attending Camp Wonder.- Dermatologists play a vital role in the care provided at Camp Wonder.- Involvement in Camp Wonder can be through volunteering or donations.- The future of dermatology holds promise with new treatments and technologies.- Genetic therapies are on the horizon for skin conditions.- Community support is essential for individuals with skin diseases.  Chapters 00:00 - Introduction to the Future of Dermatology Podcast00:54 - Soroush Aboutalebi's Skin Journey05:06 - The Importance of Compounding in Dermatology08:08 - Camp Wonder: A Safe Haven for Kids with Skin Conditions10:49 - Building Confidence Through Camp Experiences13:46 - The Role of Dermatologists at Camp Wonder16:16 - Getting Involved with Camp Wonder20:14 - Future of Dermatology: Hope for New Treatments
• 
  Episode 115: Dermatology in Art | The Future of Dermatology Podcast 02.12.2025 24min

  Summary In this episode of the Future of Dermatology podcast, Dr. Vail Reese explores the fascinating intersection of dermatology and art throughout history. He discusses how skin conditions have been represented in various art forms, the cultural implications of these representations, and how they relate to modern perceptions of beauty and villainy in movies. The conversation also touches on the future of dermatology in relation to art and cultural shifts, including the portrayal of skin conditions in anime and digital art. Read Dr. Reese's article, co-authored by Jenmesh Patel, "The Art of Skin," https://dermpub.foleon.com/dermpub-february/volume-2-issue-1/dr-vail-reese Takeaways - Dermatology has historical roots in art and culture.- Skin conditions have been depicted in art for centuries.- Cultural stigma around skin conditions has evolved over time.- The Renaissance marked a shift in realistic portrayals of skin.- Villainous characters in movies often have visible skin conditions.- Syphilis was a significant concern in historical dermatology.- The Mona Lisa features a skin condition, showcasing art's attention to detail.- Beauty marks have cultural significance and historical context.- Modern art may shift away from realistic depictions of skin.- Anime portrays scars positively, reflecting cultural attitudes towards imperfections. Chapters 00:00 - Introduction to Dermatology and Art01:23 - The Intersection of Dermatology and Historical Art05:05 - Cultural Perspectives on Skin Conditions09:30 - Villainy and Skin in Movies13:01 - Syphilis and Its Representation in Art16:31 - The Mona Lisa: A Skin Condition Revealed18:22 - Beauty Marks and Cultural Significance21:12 - Future Trends in Dermatology and Art
• 
  Episode 114: Steroid Withdrawal Syndrome | The Future of Dermatology Podcast 25.11.2025 22min

  Summary This episode of The Future of Dermatology Podcast delves into various aspects of eczema management, exploring personal experiences, treatment options, and future research directions. Dr. Larry Eichenfield uses metaphors of tools to describe their approach to managing eczema, emphasizing the importance of having a variety of strategies at their disposal. Takeaways - Eczema management requires a toolbox of strategies.- Personal experiences can shape treatment approaches.- Understanding different treatment options is crucial.- Future research may lead to better eczema solutions.- Metaphors can help explain complex health issues.- Community support plays a role in managing eczema.- Education about eczema is essential for patients.- Innovative treatments are on the horizon.- Holistic approaches can complement traditional treatments.- Individualized care is key to effective management. Chapters 00:00 - Introduction to Topical Steroid Withdrawal